| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| ACRV | Acrivon Therapeutics |  | -- | -- | -- | -- | ||
| Pre Market |  | 1.34 | -0.74% | |||||
| ACRS | Aclaris Therapeutics | | -- | -- | -- | -- | ||
| Pre Market |  | 1.6388 | +3.07% | |||||
| ACHV | Achieve Life Sciences | | -- | -- | -- | -- | ||
| Pre Market | | 2.39 | +2.58% | |||||
| ABSI | Absci Corp | | -- | -- | -- | -- | ||
| Pre Market | | 2.73 | 0.00% | |||||
| ABP | Abpro Holdings Inc | | -- | -- | -- | -- | ||
| Pre Market | | 0.1939 | -0.41% | |||||
| ABVX | Abivax SA | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ABEO | Abeona Therapeutics | | -- | -- | -- | -- | ||
| Pre Market | | 5.81 | -0.68% | |||||
| ABCL | AbCellera Biologics | | -- | -- | -- | -- | ||
| Pre Market | | 4.26 | +0.24% | |||||
| AARD | Aardvark Therapeutics Inc | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ATAI | ATAI Life Sciences NV | | -- | -- | -- | -- | ||
| Pre Market | | 2.6907 | -1.44% | |||||
| SPRY | ARS Pharmaceuticals | | -- | -- | -- | -- | ||
| Pre Market | | 17.57 | -2.28% | |||||
| ANTX | AN2 Therapeutics | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ALXO | ALX Oncology Holdings | | -- | -- | -- | -- | ||
| Pre Market | | 0.526801 | +6.00% | |||||
| AIM | AIM ImmunoTech Inc | | -- | -- | -- | -- | ||
| Pre Market | | 8.7 | -7.02% | |||||
| AEON | AEON Biopharma | | -- | -- | -- | -- | ||
| Pre Market | | 0.8699 | +1.15% | |||||
| ADMA | ADMA Biologics | | -- | -- | -- | -- | ||
| Pre Market | | 18.3434 | -0.69% | |||||
| ADCT | ADC Therapeutics SA | | -- | -- | -- | -- | ||
| Pre Market | | 3.27 | -0.91% | |||||
| ACAD | ACADIA Pharmaceuticals | | -- | -- | -- | -- | ||
| Pre Market | | 22.18 | +0.54% | |||||
| ACIU | AC Immune SA | | -- | -- | -- | -- | ||
| Pre Market | | 2.13 | +0.95% | |||||
| ABVC | ABVC BioPharma | | -- | -- | -- | -- | ||
| Pre Market | | 3.47 | +3.58% | |||||
 | Quotes are at least 15-min delayed：2025/07/11 09:09 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |
